|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01358 PW MEDTECH
Nominal 
0.980 -0.010 (-1.010%) | 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | 768,903 | 13.897% | 675,084 | 536,826 | 271,399 | 247,352 |
| Cost of Sales | (349,455) | 18.787% | (294,187) | (238,001) | (105,343) | (98,748) |
| Gross Profit | 419,448 | 10.121% | 380,897 | 298,825 | 166,056 | 148,604 |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | (1,182) | 1837.705% | (61) | (250) | (52,591) | (1,753) | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | (6,100) | -- | 731,750 | 587,715 | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 113,410 | |
| Profit / (Loss) before Taxation | 229,753 | -0.569% | 231,067 | 157,747 | 737,464 | 626,599 | |
| Taxation | (37,231) | 42.954% | (26,044) | (28,880) | 1,653 | 5,212 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (41,742) | -19.478% | (51,839) | (22,826) | 3 | 3 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 150,780 | -1.569% | 153,184 | 106,041 | 739,120 | 631,814 | |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (50,272) | 15.115% | (43,671) | (34,904) | (56,730) | 5,126 |
| Depreciation & Amortisation | 117,746 | 19.830% | 98,261 | 78,586 | 31,415 | 28,435 |
| Directors' Emoluments | 2,217 | 0.544% | 2,205 | 2,127 | 3,861 | 2,164 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | 9.770 | -0.102% | 9.780 | 6.770 | 47.100 | 40.260 |
| DPS (cts) | 9.051 | -- | 8.933 | 0.000 | 0.000 | 133.013 |
| Dividend Payout Ratio (%) | 92.637% | -- | 91.336% | -- | -- | 330.384% |
| Cash flow per share ($) | -- | -- | 0.135 | 0.172 | 0.024 | 0.050 |
| NBV per share ($) | 2.671 | -- | 2.583 | 2.520 | 2.417 | 3.255 |
| Remarks: | Real time quote last updated: 16/04/2025 17:22 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 150,780,000 |
| %Change | -1.569% |
| EPS / (LPS) | RMB 0.098 |
| NBV Per Share (¥) | RMB 2.671 |